Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
GLP-1
Pharma
Lilly answers FDA's call for more Foundayo safety information
Lilly is wasting no time pursuing the next indication for its obesity pill Foundayo as it appeases an FDA request for more safety info in parallel.
Fraiser Kansteiner
Apr 16, 2026 9:43am
Takeda-Denali, Merck-Zhifei, Shionogi—Fierce Pharma Asia
Apr 10, 2026 8:00am
Vanda tests motion sickness drug Nereus in GLP-1 patients
Apr 9, 2026 2:56pm
Analysts pin high hopes early on Lilly's Foundayo launch
Apr 2, 2026 11:42am
Pulse check on Lilly's GLP-1 fortunes
Mar 27, 2026 9:00am
Takeda, GLP-1 generics, Gilead—Fierce Pharma Asia
Mar 27, 2026 8:38am
